$6.68
0.6811.33%
At close: Jun 10, 5:00 PM EST
$6.82
0.8213.67%
Pre-Market: 7:00 AM EST
Silence Therapeutics PLC Earnings Estimates
SLNNASDAQ
PRO
Silence Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SLN
Silence Therapeutics (SLN) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.15 and quarterly revenue of $886.53K.
In the most recent quarter (Q1), Silence Therapeutics reported EPS of $-0.11, beating estimates of $-0.21 by 0.48%. Revenue came in at $422.00K, missing the estimate of $2.44M by 0.83%.
Silence Therapeutics has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Silence Therapeutics has averaged an EPS surprise of 0.73% and a revenue surprise of 0.94%.
Earnings Date
Aug 6
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$886.53K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$839.00K
Silence Therapeutics Earnings History
Analyze the earnings history of Silence Therapeutics using advanced sorting and filters.
Loading calendar...
Silence Therapeutics (SLN) Earnings Per Share
The chart below shows Silence Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Silence Therapeutics (SLN) Revenue
The chart below shows Silence Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?
Silence Therapeutics (SLN) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Silence Therapeutics (NASDAQ:SLN)?
The Actual EPS was $-0.11, which beat the estimate of $-0.21.
What were Silence Therapeutics’s (NASDAQ:SLN) revenues?
The Actual Revenue was $422.00K, which missed the estimate of $2.44M.
